Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fibroblast Growth Factor Receptor Signaling in Maturing Osteoblasts Controls Cell-Matrix Interactions Critical for Osteocyte Survival.

bioRxiv : the preprint server for biology·2026

Same author

Programmable dendritic systems for active fluidics and motility.

Chemical communications (Cambridge, England)·2026

Same author

Palladium on S,N-containing carbon materials derived from covalent triazine-based frameworks (CTFs) for C-C coupling and electrocatalytic hydrogen production.

Nanoscale·2026

Same author

Programming self-powered motion <i>via</i> "host-guest" recognition.

Chemical communications (Cambridge, England)·2026

Same author

Resolving the design principles that control post-natal vascular growth and scaling.

Cell systems·2025

Same author

Disulfide-mediated ruthenium-catalyzed direct C-H thiolation in benzoxazinone systems: selective synthesis of <i>ortho</i>-thiolated 2-arylbenzoxazinones.

Organic & biomolecular chemistry·2025

Search research articles

Related Experiment Video

Updated: May 25, 2026

Synovial Fluid Analysis to Identify Osteoarthritis

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

Evolving biomarkers in osteoarthritis.

Debabrata Patra¹, Linda J Sandell

¹Department of Orthopaedic Surgery, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA.

The Journal of Knee Surgery

|February 7, 2012

Summary

This summary is machine-generated.

Biomarkers are crucial for diagnosing osteoarthritis (OA) early and monitoring treatment. This review explores current biochemical, genetic, and emerging lipidomic and metabolomic biomarkers for effective OA management.

More Related Videos

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Related Experiment Videos

Last Updated: May 25, 2026

Synovial Fluid Analysis to Identify Osteoarthritis

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Area of Science:

Biochemistry
Genetics
Metabolomics
Lipidomics

Background:

Osteoarthritis (OA) is a debilitating disease with significant socioeconomic impact.
Challenges in early diagnosis and prognosis stem from population heterogeneity and incomplete understanding of OA.
Current radiographic methods for early OA diagnosis are insufficient, necessitating biomarker identification.

Purpose of the Study:

To review current biochemical biomarkers for osteoarthritis (OA).
To discuss the applications and limitations of existing OA diagnostic and prognostic tools.
To explore emerging biomarkers, including genetic, lipidomic, and metabolomic markers, for early OA detection.

Main Methods:

Review of current literature on osteoarthritis biomarkers.
Analysis of biochemical, genetic (single nucleotide polymorphisms), lipidomic, and metabolomic approaches.
Evaluation of biomarker applications in early diagnosis, prognosis, and treatment monitoring.

Main Results:

Existing biochemical biomarkers have applications but also limitations in OA management.
Genetic biomarkers like single nucleotide polymorphisms show potential for OA risk assessment.
Lipidomics and metabolomics are emerging fields offering novel biomarkers for early OA detection.

Conclusions:

There is a critical need for improved biomarkers for early osteoarthritis diagnosis and patient management.
Current biochemical markers are useful but limited; emerging genetic and omics technologies offer promising alternatives.
Further research into novel biomarkers is essential for advancing OA diagnostics, prognostics, and therapeutic monitoring.